Comparison of Human Insulin Produced by the Current Process and the NN729 Process in Type 1 Diabetes
NCT ID: NCT00569400
Last Updated: 2017-02-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
241 participants
INTERVENTIONAL
2003-05-01
2004-01-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults With Type 2 Diabetes
NCT07112339
To Compare the Effect of Inhaled Insulin With Subcutaneously Injected Insulin in Subjects With Type 2 Diabetes Mellitus.
NCT00419302
Safety and Efficacy of Insulin NPH Compared to a New Insulin Formulation in Subjects With Type 2 Diabetes
NCT00660374
Safety and Efficacy of Biphasic Human Insulin Compared to EX1000 in Type 2 Diabetes
NCT00698802
A Study to Look at How Safe Insulin NNC0471-0119 is and How it Works in People With Type 1 Diabetes Mellitus
NCT04655690
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
human insulin
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Basal/bolus treatment with human insulin for at least 2 months preceding trial start
* Body Mass Index (BMI) lesser than or equal to 35.0 kg/m2
* HbA1c lesser than or equal to 12.0%
Exclusion Criteria
* Any condition that the investigator and/or sponsor feel would interfere with trial participation
* Known or suspected allergy against trial product or related products
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Novo Nordisk A/S
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Global Clinical Registry (GCR, 1452)
Role: STUDY_DIRECTOR
Novo Nordisk A/S
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Novo Nordisk Investigational Site
Broadmeadow, New South Wales, Australia
Novo Nordisk Investigational Site
Keswick, South Australia, Australia
Novo Nordisk Investigational Site
Dunedin, , Australia
Novo Nordisk Investigational Site
Hamilton, , Australia
Novo Nordisk Investigational Site
Kippa-Ring, , Australia
Novo Nordisk Investigational Site
Miranda, , Australia
Novo Nordisk Investigational Site
Stones Corner, , Australia
Novo Nordisk Investigational Site
Shatin, New Territories, , Hong Kong
Novo Nordisk Investigational Site
Cheras, , Malaysia
Novo Nordisk Investigational Site
Georgetown, Penang, , Malaysia
Novo Nordisk Investigational Site
Kota Bharu, Kelantan, , Malaysia
Novo Nordisk Investigational Site
Cebu City, , Philippines
Novo Nordisk Investigational Site
Iloilo City, , Philippines
Novo Nordisk Investigational Site
Makati City, , Philippines
Novo Nordisk Investigational Site
Marikina City, , Philippines
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Clinical Trials at Novo Nordisk
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NN729-1541
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.